EFTA02411684.pdf

To: Jeffrey Epsteinfleeyacationagmail.comj From: Rich Kahn Sent Tue 11/23/2010 7:10:19 PM Subject re: due diligence Adam seems very insecure with me speaking with Walnut (see below) Based on my previous email I think speaking with Walnut to hear their perspective is imperative I know you said you were ok with this —just wanted to verify nothing has changed as Adam has inferred below I find dealing with Adam very difficult has he is extremely childish and a terrible business man Rich Kahn HBRK Associates Inc. New York, NY 10065 From: Adam Bly [mailto Sent: Monday, November 22, 2010 7:52 PM To: Rich Kahn Subject: Re: RE: Rich, I want to clarify what appears to be a miscommunication. This is not at all a question of whose perspective I want you to hear, Innovium vs. Walnut; of course you can gather all perspectives and formulate your own as part of your due diligence and I would be happy to facilitate any communication you seek. I raised this as an issue because of certain sensitivities and conditions expressed by Jeffrey that I want to make sure I abide by (as well as strategies that are already in motion). Let's discuss this on the phone in more detail. EFTA_R1_01473111 EFTA02411684 Adam On Nov 22, 2010, at 5:01 PM, Rich Kahn wrote: I do not want to hear the rosy picture from Innovium I want to hear Walnuts interpretation whether or not it is tainted in your eyes Please respond to my email regarding interest due Rich Kahn HBRK Associates Inc. New York, NY 10065 From: Adam Bly (maillipptip” Sent: Monday, Novem To: Rich Kahn Cc: Vera Savcic Subject: Re: Rich, Pm not sure that's the best next move. I think Innovium before walnut. Vera and/or I will call you in the morning to discuss. EFTA_R1_01473112 EFTA02411685 Sent from my iPhonc On Nov 22, 2010, at 4:25 PM, "Rich Kahn" I would like your permission to speak to Walnut Please advise Rich Kahn HBRK Associates Inc. New York, NY 10065 Adam Bly Founder/CEO Seed I I New York, NY 10010 www.seedmediaciroup.com wrote: EFTA_R1_01473113 EFTA02411686